The involvement of circulating miR‐146a and miR‐27a in patients with atherosclerotic cardiovascular disease after SARS‐CoV‐2 infection
J Zhou, C Wei, G Li, W He, M Song, X Liu… - Clinical …, 2024 - Wiley Online Library
Background Atherosclerotic cardiovascular disease (ASCVD) is a group of clinical diseases
based on pathology of atherosclerosis that is the leading cause of mortality worldwide …
based on pathology of atherosclerosis that is the leading cause of mortality worldwide …
Alterations in circulating miRNA levels after infection with SARS-CoV-2 could contribute to the Development of Cardiovascular diseases: what we know so far
The novel coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) and poses significant complications for …
syndrome coronavirus 2 (SARS-CoV-2) and poses significant complications for …
Downregulation of microRNA-146a in diabetes, obesity and hypertension may contribute to severe COVID-19
J Roganović - Medical Hypotheses, 2021 - Elsevier
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is able to
produce an excessive host immune reaction and may leads to severe disease-a life …
produce an excessive host immune reaction and may leads to severe disease-a life …
[HTML][HTML] MiR-200c-3p expression may be associated with worsening of the clinical course of patients with COVID-19
COVID-19 represents a public health emergency, whose mechanism of which is not fully
understood. It is speculated that microRNAs may play a crucial role in host cells after …
understood. It is speculated that microRNAs may play a crucial role in host cells after …
miR-146a, miR-221, and miR-155 are involved in inflammatory immune response in severe COVID-19 patients
N Gaytán-Pacheco, A Ibáñez-Salazar… - Diagnostics, 2022 - mdpi.com
COVID-19 infection triggered a global public health crisis during the 2020–2022 period, and
it is still evolving. This highly transmissible respiratory disease can cause mild symptoms up …
it is still evolving. This highly transmissible respiratory disease can cause mild symptoms up …
Analysis of serum microRNAs and rs2910164 GC single-nucleotide polymorphism of miRNA-146a in COVID-19 patients
C Pinacchio, M Scordio, L Santinelli… - … of Immunoassay and …, 2022 - Taylor & Francis
Alteration of micro-RNAs (miRNAs) expression, including miRNA-122a,− 146a and− 205
family members, can have profound effects on inflammatory and IFN pathways (miRNA …
family members, can have profound effects on inflammatory and IFN pathways (miRNA …
Systematic levels of IL-29 and microRNA185-5p were not associated with severe COVID-19 in the Iranian population
Background Increased systematic pro-inflammatory cytokines is the main cause of the
inflammatory conditions of the hospitalized severe acute respiratory syndrome coronavirus 2 …
inflammatory conditions of the hospitalized severe acute respiratory syndrome coronavirus 2 …
Expression level of non-coding (MiR-155) gene as biomarker for severity of Coronaviruses infection among vaccinated and non-vaccinated Iraqi patients
BACKGROUND: The COVID-19 pandemic caused by SARS-CoV-2 is influenced by genetic
and epigenetic factors, including miR-155, which affects immune cell and virus functions and …
and epigenetic factors, including miR-155, which affects immune cell and virus functions and …
miR-155: A potential biomarker for predicting mortality in COVID-19 patients
R Kassif-Lerner, K Zloto, N Rubin, K Asraf… - Journal of Personalized …, 2022 - mdpi.com
COVID-19, a pandemic of severe acute respiratory syndrome caused by Coronavirus 2
(SARS-CoV-2), continues to pose diagnostic and therapeutic challenges due to its …
(SARS-CoV-2), continues to pose diagnostic and therapeutic challenges due to its …
SARS-CoV2 infection induce miR-155 expression and skewed Th17/Treg balance by changing SOCS1 level: A clinical study
MS Soltani-Zangbar, M Hajivalili, D Daneshdoust… - Cytokine, 2023 - Elsevier
Background One of the regulators in severe acute respiratory syndrome coronavirus2
(SARS-CoV2) infection is miRNAs. In COVID-19 patients, immunological responses to …
(SARS-CoV2) infection is miRNAs. In COVID-19 patients, immunological responses to …